Light Isotope-Enriched Antibacterial Composition for Resistant Infections
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current antibacterial compositions often cause toxic effects and contribute to the development of resistant microorganisms, necessitating the need for a new, effective antibacterial agent that does not have these drawbacks.
Innovation Solution
An antibacterial composition enriched with light isotopes such as 1H, 12C, 16O, 14N, 39K, 24Mg, 64Zn, 85Rb, 28Si, 54Fe, 92Mo, 74Se, 58Ni, 70Ge, 52Cr, and 63Cu, which are present in bacteriostatic or bactericidal effective amounts, formulated for various administration routes including topical and oral forms, and can be used in human and veterinary medicine.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional antibiotics are used to treat bacterial infections, then bacterial growth is inhibited and bacteria are killed, but toxic effects are caused and resistant microorganisms develop
Solution Approach 1:
The patent applies parameter changes by substituting the isotopic composition parameter of the active ingredient. Conventional antibiotics use standard isotopic ratios, while this invention uses light isotope-enriched forms (e.g., 97.5% 63Cu, 98% 64Zn, 99.9% 1H) to achieve enhanced antibacterial activity with reduced toxicity and resistance development. This changes the physical parameter of isotopic abundance to resolve the contradiction between effectiveness and harmful effects
Solution Approach 2:
The patent employs the copying principle by creating an isotopically modified version of essential elements that are already present in biological systems. Instead of using completely foreign substances, it uses light isotope versions of elements like hydrogen, carbon, oxygen, zinc, and copper that naturally occur in bacteria, but with altered isotopic ratios that disrupt bacterial autocatalytic reactions while being less harmful to host cells
2Object-affected harmful factors
If light isotopes are used to achieve bacteriostatic and bactericidal effects, then toxic effects and resistance development are avoided, but the composition complexity increases
Solution Approach 1:
The patent simplifies the formulation complexity by focusing on changing a single parameter - the isotopic composition - rather than creating complex molecular structures or combinations. The active ingredients are simple elements or compounds (water, salts, sugars) with their isotopic ratios modified, making the formulation relatively straightforward despite the sophisticated isotopic enrichment process
Solution Approach 2:
The patent extracts only the essential antibacterial component - the light isotope-enriched elements - from complex antibiotic molecules. By using simple elements and compounds with modified isotopic composition rather than complex synthetic antibiotic structures, the formulation is simplified while maintaining effectiveness
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The composition exhibits pronounced bacteriostatic and bactericidal effects comparable to conventional antibiotics without causing toxic effects or promoting resistance, effectively inhibiting bacterial growth and killing bacteria while optimizing biological functions of the involved elements.
Implementation Method 1
The variability of isotopes is known as the isotope effect, a term describing the mass-dependent variations of natural isotope contents for a particular element. The isotope effect is a consequence of the Heisenberg uncertainty principle on 75 levels of the energy distribution of molecular vibrations
Implementation Method 2
Biochemical processes of organisms are highly dependent on the conditions of their occurrence, usually using resonant effects, so the slightest deformations of electron orbitals can lead to disruption of biochemical reactions
Data Source
AI summary
An antibacterial composition that comprises as active compound at least one light isotope of an element selected from the group which consists of 1H, 12C, 16O, 14N, 39K, 24Mg, 64Zn, 85Rb, 28Si, 54Fe, 92Mo, 74Se, 58Ni, 70Ge, 52Cr, 63Cu, 50V, or combinations thereof, wherein the composition is enriched for the at least one light isotope. A method of treating and preventing bacterial diseases in humans and non-human animals by administering the composition. The use of the said composition in human and veterinary medicine for the prevention and treatment of diseases in humans and non-human animals and also as an antiseptic and disinfectant.